Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pulsar Helium Inc. is a dedicated helium exploration and development company focused on identifying and progressing high-grade helium assets in North America and Greenland. Its flagship asset is the Topaz project in Minnesota, USA, which has demonstrated some of the highest helium concentrations ever recorded globally. The company targets primary helium deposits, which offers a more sustainable and environmentally friendly supply compared to helium produced as a byproduct of natural gas. Pulsar's mission is to provide a reliable supply of helium for critical sectors, including healthcare, where it is indispensable for cooling MRI machines. The company is publicly traded on the TSX Venture Exchange and the OTCQB, positioning itself as a leader in the emerging primary helium market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pulsar Helium.